TABLE OF CONTENTS

Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Key Trends
1.3. Global & Segmental Market Estimates & Forecasts, 2015-2025 (USD Billion)
1.3.1. Viral Vector Manufacturing Market, by Type, 2015-2025 (USD Billion)
1.3.2. Viral Vector Manufacturing Market, by Disease, 2015-2025 (USD Billion)
1.3.3. Viral Vector Manufacturing Market, by Application, 2015-2025 (USD Billion)
1.3.4. Viral Vector Manufacturing Market, by End-Use, 2015-2025 (USD Billion)
1.3.5. Viral Vector Manufacturing Market, by Region, 2015-2025 (USD Billion)
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Viral Vector Manufacturing Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Industry Evolution
2.2.2. Scope of the Study
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Viral Vector Manufacturing Market Dynamics
3.1. See Saw Analysis
3.1.1. Market Drivers
3.1.2. Market Challenges
3.1.3. Market Opportunities
Chapter 4. Global Viral Vector Manufacturing Market Industry Analysis
4.1. Porter's 5 Force Model
4.1.1. Bargaining Power of Buyers
4.1.2. Bargaining Power of Suppliers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter's 5 Force Model
4.2. PEST Analysis
4.2.1. Political Scenario
4.2.2. Economic Scenario
4.2.3. Social Scenario
4.2.4. Technological Scenario
4.3. Key Buying Criteria
4.4. Regulatory Framework
4.5. Investment Vs Adoption Scenario
4.6. Analyst Recommendation & Conclusion
Chapter 5. Global Viral Vector Manufacturing Market, by Type
5.1. Market Snapshot
5.2. Market Performance - Potential Model
5.3. Viral Vector Manufacturing Market, Sub Segment Analysis
5.3.1. Adenoviral
5.3.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
5.3.1.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
5.3.2. Retroviral
5.3.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
5.3.2.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
5.3.3. Adeno-Associated
5.3.3.1. Market estimates & forecasts, 2015-2025 (USD Billion)
5.3.3.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
5.3.4. Others
5.3.4.1. Market estimates & forecasts, 2015-2025 (USD Billion)
5.3.4.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)

Chapter 6. Global Viral Vector Manufacturing Market, by Disease
6.1. Market Snapshot
6.2. Market Performance - Potential Model
6.3. Viral Vector Manufacturing Market, Sub Segment Analysis
6.3.1. Genetic Disorders
6.3.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
6.3.1.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
6.3.2. Infectious Diseases
6.3.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
6.3.2.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
6.3.3. Cancers
6.3.3.1. Market estimates & forecasts, 2015-2025 (USD Billion)
6.3.3.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
6.3.4. Others
6.3.4.1. Market estimates & forecasts, 2015-2025 (USD Billion)
6.3.4.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)

Chapter 7. Global Viral Vector Manufacturing Market, by Application
7.1. Market Snapshot
7.2. Market Performance - Potential Model
7.3. Viral Vector Manufacturing Market, Sub Segment Analysis
7.3.1. Vaccinology
7.3.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
7.3.1.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.3.2. Gene Therapy
7.3.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
7.3.2.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)

Chapter 8. Global Viral Vector Manufacturing Market, by End-Use
8.1. Market Snapshot
8.2. Market Performance - Potential Model
8.3. Viral Vector Manufacturing Market, Sub Segment Analysis
8.3.1. Research Institutes
8.3.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
8.3.1.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
8.3.2. Biopharmaceutical & Pharmaceutical Companies
8.3.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
8.3.2.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
8.3.3. Others
8.3.3.1. Market estimates & forecasts, 2015-2025 (USD Billion)
8.3.3.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
Chapter 9. Global Viral Vector Manufacturing Market, by Regional Analysis
9.1. Viral Vector Manufacturing Market, Regional Market Snapshot (2015-2025)
9.2. North America Viral Vector Manufacturing Market Snapshot
9.2.1. U.S.
9.2.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
9.2.1.2. Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.2.1.3. Disease breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.2.1.4. Application breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.2.1.5. End-Use breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.2.2. Canada
9.2.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
9.2.2.2. Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.2.2.3. Disease breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.2.2.4. Application breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.2.2.5. End-Use breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.3. Europe Viral Vector Manufacturing Market Snapshot
9.3.1. U.K.
9.3.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
9.3.1.2. Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.3.1.3. Disease breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.3.1.4. Application breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.3.1.5. End-Use breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.3.2. Germany
9.3.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
9.3.2.2. Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.3.2.3. Disease breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.3.2.4. Application breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.3.2.5. End-Use breakdown estimates & forecasts, 2015-2025 (USD Billion)

9.3.3. Rest of Europe
9.3.3.1. Market estimates & forecasts, 2015-2025 (USD Billion)
9.3.3.2. Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.3.3.3. Disease breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.3.3.4. Application breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.3.3.5. End-Use breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.4. Asia Viral Vector Manufacturing Market Snapshot
9.4.1. China
9.4.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
9.4.1.2. Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.4.1.3. Disease breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.4.1.4. Application breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.4.1.5. End-Use breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.4.2. India
9.4.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
9.4.2.2. Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.4.2.3. Disease breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.4.2.4. Application breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.4.2.5. End-Use breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.4.3. Japan
9.4.3.1. Market estimates & forecasts, 2015-2025 (USD Billion)
9.4.3.2. Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.4.3.3. Disease breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.4.3.4. Application breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.4.3.5. End-Use breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.4.4. Rest of Asia Pacific
9.4.4.1. Market estimates & forecasts, 2015-2025 (USD Billion)
9.4.4.2. Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.4.4.3. Disease breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.4.4.4. Application breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.4.4.5. End-Use breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.5. Latin America Viral Vector Manufacturing Market Snapshot
9.5.1. Brazil
9.5.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
9.5.1.2. Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.5.1.3. Disease breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.5.1.4. Application breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.5.1.5. End-Use breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.5.2. Mexico
9.5.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
9.5.2.2. Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.5.2.3. Disease breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.5.2.4. Application breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.5.2.5. End-Use breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.6. Rest of The World
9.6.1. South America
9.6.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
9.6.1.2. Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.6.1.3. Disease breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.6.1.4. Application breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.6.1.5. End-Use breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.6.2. Middle East and Africa
9.6.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
9.6.2.2. Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.6.2.3. Disease breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.6.2.4. Application breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.6.2.5. End-Use breakdown estimates & forecasts, 2015-2025 (USD Billion)
Chapter 10. Competitive Intelligence
10.1. Company Market Share (Subject to Data Availability)
10.2. Top Market Strategies
10.3. Company Profiles
10.3.1. CGT Catapult
10.3.1.1. Overview
10.3.1.2. Financial (Subject to Data Availability)
10.3.1.3. Product Summary
10.3.1.4. Recent Developments
10.3.2. Lonza
10.3.3. Uniqure
10.3.4. Merck
10.3.5. Cobra Biologics
10.3.6. Oxford BioMedica
10.3.7. Novasep
10.3.8. Spark Therapeutics
Chapter 11. Research Process
11.1. Research Process
11.1.1. Data Mining
11.1.2. Analysis
11.1.3. Market Estimation
11.1.4. Validation
11.1.5. Publishing
11.1.6. Research Assumption